+

WO2008105325A1 - Boisson contenant de la citrulline - Google Patents

Boisson contenant de la citrulline Download PDF

Info

Publication number
WO2008105325A1
WO2008105325A1 PCT/JP2008/053013 JP2008053013W WO2008105325A1 WO 2008105325 A1 WO2008105325 A1 WO 2008105325A1 JP 2008053013 W JP2008053013 W JP 2008053013W WO 2008105325 A1 WO2008105325 A1 WO 2008105325A1
Authority
WO
WIPO (PCT)
Prior art keywords
citrulline
weight
containing beverage
beverage
disclosed
Prior art date
Application number
PCT/JP2008/053013
Other languages
English (en)
Japanese (ja)
Inventor
Yasushi Sakai
Ayako Kamimura
Original Assignee
Kyowa Hakko Bio Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co., Ltd. filed Critical Kyowa Hakko Bio Co., Ltd.
Priority to JP2009501212A priority Critical patent/JP5534806B2/ja
Publication of WO2008105325A1 publication Critical patent/WO2008105325A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne une boisson qui peut exercer diverses fonctions utiles d'arginine, est facile à boire et a une excellente stabilité. L'invention concerne spécifiquement une boisson contenant 0,5 à 10 % en poids de citrulline, 0,1 à 40 % en poids d'un sucre et 0,1 à 5 % en poids d'un acide organique.
PCT/JP2008/053013 2007-02-23 2008-02-22 Boisson contenant de la citrulline WO2008105325A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009501212A JP5534806B2 (ja) 2007-02-23 2008-02-22 シトルリン含有飲料

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-043098 2007-02-23
JP2007043098 2007-02-23

Publications (1)

Publication Number Publication Date
WO2008105325A1 true WO2008105325A1 (fr) 2008-09-04

Family

ID=39721160

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053013 WO2008105325A1 (fr) 2007-02-23 2008-02-22 Boisson contenant de la citrulline

Country Status (2)

Country Link
JP (1) JP5534806B2 (fr)
WO (1) WO2008105325A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009064004A1 (fr) * 2007-11-16 2009-05-22 Kyowa Hakko Bio Co., Ltd. Boisson contenant de la citrulline
JP2009171860A (ja) * 2008-01-22 2009-08-06 Asahi Soft Drinks Co Ltd シトルリン含有飲食品及びその製造方法
JP2012140378A (ja) * 2010-12-29 2012-07-26 Kracie Home Products Ltd チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物
JP2012144457A (ja) * 2011-01-07 2012-08-02 Kracie Home Products Ltd 抗酸化剤、化粧料、飲食品組成物及び医薬品組成物
JP2013060406A (ja) * 2011-09-15 2013-04-04 Kyowa Hakko Bio Co Ltd 脳疲労改善用経口剤
JP2013066440A (ja) * 2011-09-22 2013-04-18 House Foods Corp 飲料組成物
JP2016121194A (ja) * 2016-04-05 2016-07-07 協和発酵バイオ株式会社 脳疲労改善用経口剤
US20220061357A1 (en) * 2014-08-21 2022-03-03 Clearfast Inc. Powdered pre-operative beverage composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193342A1 (en) * 2001-05-09 2002-12-19 Hamman John P. Modifying undesirable tastes
WO2003088947A1 (fr) * 2002-04-22 2003-10-30 Experimental & Applied Sciences, Inc. Complements alimentaires contenant une combinaison de 4-hydroxyisoleucine et de creatine
US20050256192A1 (en) * 2004-04-30 2005-11-17 Gardiner Paul T Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual
WO2006034586A1 (fr) * 2004-09-29 2006-04-06 Aplodan Formulations Ltd. Composition nutritive favorisant la performance musculaire et agissant comme bloqueur d'hydrogene (h+)
US20060147602A1 (en) * 2004-10-07 2006-07-06 Next Proteins, Inc. High energy carbonated protein drink and method of making
WO2007000985A1 (fr) * 2005-06-27 2007-01-04 Kyowa Hakko Kogyo Co., Ltd. Composition prophylactique ou therapeutique pour lutter contre l'hemoglobinurie ou la myoglobinurie
WO2007023931A1 (fr) * 2005-08-25 2007-03-01 Kyowa Hakko Kogyo Co., Ltd. Préparation pour la prévention de l'augmentation de la concentration sanguine en alcool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04152869A (ja) * 1990-10-17 1992-05-26 Kazuyuki Masuzawa すいかジュース
JPH09224621A (ja) * 1996-02-23 1997-09-02 Eisuke Nakayama スイカ糖エキスの製造方法
JPH10210956A (ja) * 1997-01-28 1998-08-11 Morinaga & Co Ltd 果実飲料及びその製造法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193342A1 (en) * 2001-05-09 2002-12-19 Hamman John P. Modifying undesirable tastes
WO2003088947A1 (fr) * 2002-04-22 2003-10-30 Experimental & Applied Sciences, Inc. Complements alimentaires contenant une combinaison de 4-hydroxyisoleucine et de creatine
US20050256192A1 (en) * 2004-04-30 2005-11-17 Gardiner Paul T Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual
WO2005107735A2 (fr) * 2004-04-30 2005-11-17 Pump Formulations, Ltd. Composition nutritionnelle permettant d'ameliorer le stimulus d'un muscle maigre, la croissance, la resistance et la recuperation, creation et prolongement des pompes musculaires intensives, endurance, resistance, performance, taille et resistance, d'assurer un effet transducteur pour l'oxyde nitrique, d'augmenter l'adminis
WO2006034586A1 (fr) * 2004-09-29 2006-04-06 Aplodan Formulations Ltd. Composition nutritive favorisant la performance musculaire et agissant comme bloqueur d'hydrogene (h+)
US20060147602A1 (en) * 2004-10-07 2006-07-06 Next Proteins, Inc. High energy carbonated protein drink and method of making
WO2007000985A1 (fr) * 2005-06-27 2007-01-04 Kyowa Hakko Kogyo Co., Ltd. Composition prophylactique ou therapeutique pour lutter contre l'hemoglobinurie ou la myoglobinurie
WO2007023931A1 (fr) * 2005-08-25 2007-03-01 Kyowa Hakko Kogyo Co., Ltd. Préparation pour la prévention de l'augmentation de la concentration sanguine en alcool

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009064004A1 (fr) * 2007-11-16 2009-05-22 Kyowa Hakko Bio Co., Ltd. Boisson contenant de la citrulline
US8679568B2 (en) 2007-11-16 2014-03-25 Kyowa Hakko Bio Co., Ltd. Citrulline-containing beverage
US9375479B2 (en) 2007-11-16 2016-06-28 Kyowa Hakko Bio Co., Ltd. Citrulline containing beverage
JP2009171860A (ja) * 2008-01-22 2009-08-06 Asahi Soft Drinks Co Ltd シトルリン含有飲食品及びその製造方法
JP2012140378A (ja) * 2010-12-29 2012-07-26 Kracie Home Products Ltd チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物
JP2012144457A (ja) * 2011-01-07 2012-08-02 Kracie Home Products Ltd 抗酸化剤、化粧料、飲食品組成物及び医薬品組成物
JP2013060406A (ja) * 2011-09-15 2013-04-04 Kyowa Hakko Bio Co Ltd 脳疲労改善用経口剤
JP2013066440A (ja) * 2011-09-22 2013-04-18 House Foods Corp 飲料組成物
US20220061357A1 (en) * 2014-08-21 2022-03-03 Clearfast Inc. Powdered pre-operative beverage composition
US11758929B2 (en) * 2014-08-21 2023-09-19 Clearfast Inc. Powdered pre-operative beverage composition
JP2016121194A (ja) * 2016-04-05 2016-07-07 協和発酵バイオ株式会社 脳疲労改善用経口剤

Also Published As

Publication number Publication date
JPWO2008105325A1 (ja) 2010-06-03
JP5534806B2 (ja) 2014-07-02

Similar Documents

Publication Publication Date Title
WO2008105325A1 (fr) Boisson contenant de la citrulline
NZ603707A (en) Beer-taste beverages with foam stabilized
WO2012047986A3 (fr) Article absorbant à lotion anhydre
WO2008081542A1 (fr) Extrait de thé
WO2009060629A1 (fr) Préparation de bandage à la lidocaïne
WO2010060581A3 (fr) Association d'herbicide(s) et de phytoprotecteur(s)
MX2014006166A (es) Bebida con sabor a cerveza con poco componente del extracto, que tiene ph ajustado.
WO2008025819A3 (fr) Formulations de l'acide acétylsalicylique ou de ses dérivés dans des capsules molles, présentant une stabilité élevée
WO2010003133A3 (fr) Modulateurs de cdk
WO2008113559A3 (fr) Indolizines et dérivés analogues aza de celles-ci en tant que composés actifs sur le système nerveux central
AU2012277007A8 (en) Method of improving the aftertaste of carbonated drinks
WO2009017115A1 (fr) Boisson alcoolisée présentant une forte teneur en jus de fruit
WO2010126168A3 (fr) Préparation solide
WO2008032227A3 (fr) Formulations topiques de composés contenant du tellure
MY153750A (en) Semi-rigid partially collapsible bottles
WO2010043717A3 (fr) Compositions topiques pharmaceutiques
WO2010140765A2 (fr) Nouveau procédé de préparation de rosuvastatine, composés intermédiaires utiles pour préparer de la rosuvastatine, et procédé de préparation correspondant
MX2014006164A (es) Bebida no alcoholica con sabor a cerveza que tiene un terminado mejorado.
WO2010017918A3 (fr) Ambrisentan amorphe
WO2009072445A1 (fr) Acier pour bielles fractionnées de type fs
WO2012024597A3 (fr) Sommier roulant transformable taille basse
WO2008090740A1 (fr) Gâteaux
WO2012045072A3 (fr) Dispersion à base de sucre
MY155634A (en) Dentifrice composition
WO2009041699A1 (fr) Préparation contenant du bofutsushosan

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711787

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009501212

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08711787

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载